Article Details
Retrieved on: 2024-09-28 08:23:19
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
BOSTON, Mass., September 26, 2024- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here